Banque Cantonale Vaudoise’s Bio-Techne TECH Stock Holding History

Banque Cantonale Vaudoise’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,000	Closed	-$136K	–	1185
2023 Q3	$136K	Hold	2,000	–	–	0.01%	769
2023 Q2	$164K	Hold	2,000	–	–	0.01%	760
2023 Q1	$149K	Hold	2,000	–	–	0.01%	774
2022 Q4	$166K	Hold	2,000	–	–	0.01%	760
2022 Q3	$142K	Hold	2,000	–	–	0.01%	807
2022 Q2	$174K	Buy	+2,000	New	+$187K	0.01%	777
2021 Q4	–	Sell	-744	Closed	-$90K	–	1399
2021 Q3	$90K	Hold	744	–	–	﹤0.01%	963
2021 Q2	$84K	Sell	744 -5,336	-88%	-$562K	﹤0.01%	986
2021 Q1	$581K	Buy	6,080 +5,256	+638%	+$480K	0.03%	496
2020 Q4	$65K	Buy	+824	New	+$59.7K	﹤0.01%	909

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Banque Cantonale Vaudoise's TECH Position: Q4 2023 in Review

Banque Cantonale Vaudoise sold out of Bio-Techne (TECH) in Q4 2023, closing a stake of 2,000 shares — an estimated $136K sold.

Banque Cantonale Vaudoise first reported a position in TECH in Q4 2020 and held it in 10 quarters. The position peaked at $581K in Q1 2021. 531 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

Banque Cantonale Vaudoise reported no remaining Bio-Techne position as of Q4 2023 after selling out during the quarter.
Banque Cantonale Vaudoise sold 2,000 Bio-Techne shares in Q4 2023, an estimated $136K.
Banque Cantonale Vaudoise first reported a position in Bio-Techne in Q4 2020 and held it in 10 quarters.
Banque Cantonale Vaudoise's Bio-Techne position peaked at $581K in Q1 2021.
531 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2023, filed 7 Feb 2024.